Longwood Fund

About The Fund

Longwood Fund is a venture capital firm with a focus on the healthcare sector, specifically targeting the biotechnology, pharmaceuticals, medical devices & hospital services, healthcare & wellness, life science, and oncology industries. Founded in 2010 and based in Boston, Massachusetts, Longwood Fund is known for partnering with world-class scientific co-founders to discover and advance groundbreaking healthcare solutions that significantly improve patient lives. Aside from seed and series A funding, the firm plays an active role in the establishment and scaling of its portfolio companies, often participating as Co-Founding CEO, CBO, or President. The firm’s investment range typically falls between $100,000 and $5,000,000, with a sweet spot around $1,500,000. Longwood Fund is also recognized for organizing semi-annual industry meetings that draw together thought leaders and decision-makers from across the government, pharma, biotech, and academic spheres. These events serve as platforms for collaboration and innovation to push the envelope in medicine development. Longwood Fund takes pride in its value-add investing approach, supporting its companies in accelerating the transition of therapies from the laboratory to the patient. The firm's portfolio boasts a sustained market and exit value of $170 billion from companies that Longwood partners have co-founded. The diverse portfolio includes over 20 therapies and products brought to market and more than 35 assets in the clinic undergoing research towards approval. Longwood has co-founded 25 companies, which in turn have generated thousands of jobs in the Boston area. Through its collaborative and entrepreneurial spirit, Longwood has gained the trust and endorsement of industry leaders. Network building is an integral part of its strategy, evidenced by the robust Boston Biotech ecosystem that the firm has helped to cultivate.